| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $875K | — | -95.7% |
| R&D Expense | $33.1M | — | +3.1% |
| SG&A Expense | $10.1M | — | -1.5% |
| Operating Income | -$42.3M | — | -94.1% |
| Income Tax | $38K | — | — |
| Net Income | -$39.7M | — | -128.9% |
| EPS (Basic) | -$0.95 | — | -126.2% |
| EPS (Diluted) | -$0.95 | — | -126.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $76.4M | -15.4% | +12.7% |
| Current Assets | $266.9M | -12.9% | -33.8% |
| Total Assets | $335.5M | -11.1% | -31.0% |
| Current Liabilities | $19.2M | -21.5% | +4.1% |
| Total Liabilities | $64.7M | -9.2% | -6.6% |
| Stockholders' Equity | $270.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$41.7M | — | -8.3% |
| Capital Expenditures | $44K | — | -96.2% |
| Investing Cash Flow | $27.0M | — | +464.2% |
| Financing Cash Flow | $100K | — | -71.4% |
| Free Cash Flow | -$41.7M | — | -5.3% |
| -35.1% |